The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Gastric and gastroesophageal junction cancers are associated to a poor prognosis especially when locally advanced and metastatic stages are diagnosed. Available treatments are represented by systemic chemotherapies for which no predictive marker has been validated for clinical use. Anti-HER2 antibody, trastuzumab, has shown efficacy in these tumors, associated with 5-FU and cisplatine. However, for...
Résumé Introduction Le cancer du sein est un problème majeur de santé publique à la fois dans les pays en développement, où il représente le premier cancer féminin, et dans les pays développés, où son incidence ne cesse d’augmenter. Le marquage des récepteurs hormonaux (RH) par immunohistochimie (IHC) permet d’identifier les tumeurs hormonosensibles. La connaissance du statut HER2 est indispensable...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.